BERLIN (AP) – Slow down the race to immunize its citizens against COVID-19, Germany is facing an unknown problem. Vaccine stockpile բավարար Sufficient weapons for injection.
Like other EU countries, its national vaccine campaign lags behind Israel, Britain and the United States. There are now growing calls in the 83-million-strong country to repeal the regulation or at least rewrite it.
In January, the Germans watched the sickening spell as Britain prepared an army of volunteers to transmit coronavirus footage, and then was surprised to learn that Britain, much more affected by the epidemic than Germany, was able to vaccinate more than half a million people on certain days.
US vaccine centers and COVID-19 shootings in US grocery stores have sparked controversy in Germany, with private vaccines being dominated by the country’s own vaccine programs.
“The Anglo-Saxon countries had a much more pragmatic approach,” said Hans-Martin von Godeker, a professor of economics at Bonn University. “What usually makes the German bureaucracy stable, reliable, becomes an obstacle in times of crisis, costs lives.”
The European Medicines Agency has approved the AstraZeneca vaccine for all age groups, but a number of EU countries, including Germany, have introduced stricter age restrictions.
With a maximum of 2 million doses of AstraZeneca vaccine, Germany is seeking to empower more people to take shots that were previously restricted to a portion of the population. People in the top group are not և 65 years old.
France changed tactics earlier this week, allowing some people over the age of 65 to receive the AstraZeneca vaccine after its use was initially restricted to younger people. Health Minister Olivier Veran said the shot would soon be available to more than 50 people with health problems that make them more vulnerable.
France, which has the highest death toll in Europe of more than 87,000, received just 25 percent of the 1.6 million AstraZeneca vaccines as of Tuesday.
The age limit for AstraZeneca in European nations has been compounded by the initial delay in vaccination and some public outcry.
This week’s data from the UK Vaccine Program show that AstraZeneca and the Pfizer-BioNTech vaccine were about 60% effective in preventing symptomatic COVID-19 in people over the age of 70 after just one dose. An analysis published by Public Health England in England, which has not yet been reviewed by peers, also showed that both vaccines were about 80% effective in preventing people over the age of 80 from being hospitalized.
Belgium ալի Italy are also easing their age restrictions on the AstraZeneca vaccine as they struggle with the third concussion of COVID-19 cases due to more contagious viral variants.
In Italy, the new government of Prime Minister Mario Draghi this week ousted the tsar of COVID-19, appointing an army general with experience in logistics and experience in Kosovo and Kosovo.
At the same time, Denmark stands out as an EU vaccine success story. The Nordic country tops the alliance vaccination charts with little Malta; expects to vaccinate all adults by July, much earlier than the EU, with 70% of adults vaccinated by September.
Instead, the Danish health authorities, holding back the necessary second shot, retreated the British model, using all available vaccines, when they adopted a monitoring approach to more EU countries.
And 6 million people in Denmark have digital health records linked to a single identification number, which allows the authorities to determine exactly who is eligible for the vaccine and contact them immediately. The British authorities are sending people to post live footage.
“There are historical reasons why we do not have a centralized register, as in Denmark,” said von Godeker, referring to the history of German state repression during Nazism and Communism.
“Of course, the state can do terrible things through data,” he said. “But it can also do a lot with data.”
Targeting more affordable doses for those in need, one European country hopes to stay ahead of the virus in the coming months as more infectious variants spread.
France և Spain plans to give just one shot of two doses of vaccine to some people recovering from COVID-19, arguing that the latest infections act as partial protection against the virus.
Italy, France and the Czech Republic prioritize vaccinations in hot spots. The Hungarian leader received a Chinese COVID-19 shot over the weekend, և his country և Slovakia buys Russian Sputnik V to supplement other vaccines supplied by the EU. The President of Poland suggested that his country could follow the example of Hungary in obtaining Chinese vaccines.
The number of vaccines available in the EU next week could increase further if the European Medicines Agency reverts to US guidance in approving single-dose vaccines developed by Johnson & Johnson. President Biden said the United States now expects to deliver enough coronavirus vaccines for all adults by the end of May, two months earlier than expected.
“If we can not get the vaccine, we will obviously have a bigger problem when we get a lot of vaccines,” said Baerbel Bass, a member of the center-left Social Democrats in Germany.
The German Minister of Health said that now more than 5% of the population has received the first dose.
“But understandably, we need more speed,” said Jens Span, adding that vaccine centers would be given more flexibility in deciding who to give the shots to.
Ursula Nonnemacher, chief health official for the state of Brandenburg, which surrounds Berlin, has promised not to leave any expensive doses of the vaccine in storage, as some doctors announced on Wednesday that vaccinations would be launched.
“Now we are over-exploiting,” he said.
Raf Casert in Brussels, Jan M. M. contributed to this report. Olsen in Copenhagen, Aritz Paran in Madrid, Angela Charlton in Paris, Francis D’Emilio in Rome and Monica Skiklovska in Warsaw.
Follow the AP coverage of the virus outbreak: